Epithalon
L-alanyl-L-glutamyl-L-aspartyl-glycine
Epithalon is a synthetic tetrapeptide consisting of four amino acids (Ala-Glu-Asp-Gly) developed by Khavinson and colleagues in Russia during the late 1980s. With a molecular weight of 390.35 g/mol, this compact peptide mimics a segment of the naturally occurring thymic peptide epithalamin extracted from pineal glands, making it a valuable tool for research into telomere elongation, pineal gland function, and cellular aging processes in controlled experimental settings.
Complete Dosing Guide
How to Take Epithalon
Standard Anti-Aging Protocol
Typical Dosing:
- 5-10 mg total per cycle
- Divide into daily doses of 1-2 mg
- Administer via subcutaneous injection
Cycle Duration:
- 10-20 days per cycle
- Typically administered for 10 consecutive days
- Can extend to 20 days for enhanced effects
Frequency of Cycles:
- 2-3 cycles per year
- Space cycles 4-6 months apart
- Some protocols use quarterly cycles
Injection Schedule:
- Once or twice daily (morning and/or evening)
- If twice daily, split dose evenly
- Subcutaneous injection in abdomen or thigh
Research Protocol Variations
Low-Dose Protocol:
- 0.1-1 mg daily
- Used in some animal studies
- May be suitable for maintenance
Standard Protocol:
- 5 mg total over 10 days (0.5 mg daily)
- Common starting protocol
High-Dose Protocol:
- 10 mg total over 10-20 days
- Split into 1-2 mg daily doses
- Used in longevity research
Dosing Calculators
Dose Calculator
Unit Converter
Quick Reference:
Medical Disclaimer
Epithalon is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Long-term safety data in humans is extremely limited.